Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation.
Platz
K P
KP
Department of Surgery, Virchow Clinic, Humboldt University of Berlin, Germany.
Mueller
A R
AR
Langrehr
J M
JM
Neuhaus
P
P
Schraut
W H
WH
D000818:Animals; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology* / Q000502:physiology
D007166:Immunosuppressive Agents; D016559:Tacrolimus